Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
We have cloned a member of the steroid hormone receptor superfamily of ligand-activated transcription factors. The receptor homologue is activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes. Identification of a peroxisome proliferator-activated receptor should help elucidate the mechanism of the hypolipidaemic effect of these hepatocarcinogens and aid evaluation of their potential carcinogenic risk to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After the structure of PPAR was clarified, three PPAR isoforms (PPARα, PPARγ, and PPARδ) have been identified, each of which is encoded by a separate gene [21].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [21]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Self-citationA human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
The c-erb-A gene encodes a thyroid hormone receptor
Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., & Evans, R. M. (1986) · Nature · doi:10.1038/324641a0 · Cited by 1,477
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Self-citation
Research works printed but not linked: 8
- Reddy, J. K., Rao, M. S., Azarnoff, D. I. & Sell, S. Cancer Res. 39, 152–161 (1979).
- Sirtori, C. R., Catapano, A. & Paoletti, R. Atherosclerosis Rev. 2, 113–153 (1977).
- Warren, J. R., Simmon, V. F. & Reddy, J. K. Cancer Res. 40, 36–41 (1980).
- Kasai, H., Okadi, Y., Nishimura, S., Rao, M. S. & Reddy, J. K. Cancer Res. 49, 2603–2605 (1989).
- Marsman, D. S., Cattley, R. C., Conway, J. G. & Popp, J. A. Cancer Res. 48, 6739–6744 (1988).
- Cattley, R. C. & Popp, J. A. Cancer Res. 49, 3246–3251 (1989).
- Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
- Current Protocols in Molecular Biology (Wiley, New York, 1990).
Cited by
Items 201–300 of 1,011
Wójtowicz, S., Strosznajder, A. K., Jeżyna, M., & Strosznajder, J. B. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02993-5 · Cited by 327
Corton, J. C., Anderson, S. P., & Stauber, A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.491 · Cited by 341
Lemberger, T., Saladin, R., Vázquez, M., Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W., & Auwerx, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1764 · Cited by 329
In Vitro Bioassays for Assessing Estrogenic Substances
Zacharewski (1997) · Environmental Science & Technology · doi:10.1021/es960530o · Cited by 326
The Ah receptor and the mechanism of dioxin toxicity
Landers, J. P., & Bunce, N. J. (1991) · Biochemical Journal · doi:10.1042/bj2760273 · Cited by 323
Kong, A.-N. T., Owuor, E., Yu, R., Hebbar, V., Chen, C., Hu, R., & Mandlekar, S. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000652 · Cited by 316
“One of the first members of the nuclear hormone receptor superfamily, the peroxisome proliferator-activated receptor (PPAR),whichalsoheterodimerizeswithRXR,was initially found tobeactivatedby the lipid-loweringagentfibrate-typeofcompoundsandotherchemicals (21), andhas previously been shown to increase the levels of pe…”
BackgroundSznaidman, M. L., Haffner, C. D., Maloney, P. R., Fivush, A., Chao, E., Goreham, D., Sierra, M. L., LeGrumelec, C., Xu, H. E., Montana, V. G., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00207-5 · Cited by 312
T RANSCRIPTIONAL C ONTROL OF A DIPOGENESIS
Rangwala, S. M., & Lazar, M. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.535 · Cited by 319
Ghonem, N. S., Assis, D. N., & Boyer, J. L. (2015) · Hepatology · doi:10.1002/hep.27744 · Cited by 317
“Discovered in 1990, PPARs are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily.(10) Three distinct PPAR isoforms—a, b/d, and c—are encoded by distinct genes and show different distribution patterns.”
BackgroundThiazolidinediones as antidiabetic agents: A critical review
Nanjan, M. J., Mohammed, M., Prashantha Kumar, B. R., & Chandrasekar, M. J. N. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.02.009 · Cited by 316
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Francque, S., Szabo, G., Abdelmalek, M. F., Byrne, C. D., Cusi, K., Dufour, J.-F., Roden, M., Sacks, F., & Tacke, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00366-5 · Cited by 316
Watanabe, K., Fujii, H., Takahashi, T., Kodama, M., Aizawa, Y., Ohta, Y., Ono, T., Hasegawa, G., Naito, M., Nakajima, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000248200 · Cited by 314
Ashby, J., Brady, A., Elcombe, C. R., Elliott, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., & Purchase, I. F. H. (1994) · Human & Experimental Toxicology · doi:10.1177/096032719401300201 · Cited by 313
Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone
Sakamoto, J., Kimura, H., Moriyama, S., Odaka, H., Momose, Y., Sugiyama, Y., & Sawada, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3868 · Cited by 313
A chiroselective peptide replicator
Saghatelian, A., Yokobayashi, Y., Soltani, K., & Ghadiri, M. R. (2001) · Nature · doi:10.1038/35057238 · Cited by 310
PPARs: transcriptional effectors of fatty acids and their derivatives
Hihi, A. K., Michalik, L., & Wahli, W. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8467-x · Cited by 311
Activation of PPARδ alters lipid metabolism in db/db mice
Leibowitz, M. D., Fiévet, C., Hennuyer, N., Peinado-Onsurbe, J., Duez, H., Berger, J., Cullinan, C. A., Sparrow, C. P., Baffic, J., Berger, G. D., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01554-4 · Cited by 308
Yoshikawa, T., Ide, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Matsuzaka, T., Yatoh, S., Kitamine, T., Okazaki, H., Tamura, Y., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0190 · Cited by 297
Huber, W. W., Grasl-kraupp, B., & Schulte-hermann, R. (1996) · Critical Reviews in Toxicology · doi:10.3109/10408449609048302 · Cited by 302
Muerhoff, A. S., Griffin, K. J., & Johnson, E. F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41738-3 · Cited by 311
Shi, Y., Hon, M., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052707099 · Cited by 303
Henke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins, J. L., Harrington, Hashim, M. A., Hull-Ryde, E. A., Kaldor, I., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9804127 · Cited by 301
Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver
Rusyn, I., Peters, J. M., & Cunningham, M. L. (2006) · Critical Reviews in Toxicology · doi:10.1080/10408440600779065 · Cited by 301
“A discovery of a family of the nuclear receptors, peroxisome proliferator-activated receptors (PPARs) (Issemann and Green, 1990), shed light on the mechanism of action of PP compounds, as well as opened new opportunities for therapeutic interventions in many human diseases (Berger et al., 2005).”
BackgroundYamashita, A., Sugiura, T., & Waku, K. (1997) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021715 · Cited by 300
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Zhou, Q., & Liao, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315684 · Cited by 294
“Peroxisome proliferators-activated receptors (PPARs) are members of the nuclear steroidhormone receptor superfamily and bind to specific DNA response elements as heterodimers with the retinoid X receptor [32].”
BackgroundHondares, E., Rosell, M., Díaz-Delfín, J., Olmos, Y., Monsalve, M., Iglesias, R., Villarroya, F., & Giralt, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252775 · Cited by 295
Alessandri, J.-M., Guesnet, P., Vancassel, S., Astorg, P., Denis, I., Langelier, B., Aïd, S., Poumès-Ballihaut, C., Champeil-Potokar, G., & Lavialle, M. (2004) · Reproduction Nutrition Development · doi:10.1051/rnd:2004063 · Cited by 283
“In 1990, Issemann and Green discovered that molecules used for the treatment of hyperlipidemia act by binding on transcription factors (PPARs, peroxisome proliferators-activated receptors) that belong to the superfamily of steroid hormone receptors [126].”
BackgroundThe cytochrome P450 4 (CYP4) family
Simpson, A. E. C. M. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00246-7 · Cited by 298
Wahli, W., Braissant, O., & Desvergne, B. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90045-4 · Cited by 291
Skeletal muscle mitochondrial remodeling in exercise and diseases
Gan, Z., Fu, T., Kelly, D. P., & Vega, R. B. (2018) · Cell Research · doi:10.1038/s41422-018-0078-7 · Cited by 287
Clarke, S. D. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500000969 · Cited by 294
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
Guan, Y., & Breyer, M. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00766.x · Cited by 295
“Since the identification of the first PPAR receptor in mous”
BackgroundNuclear receptors and nonalcoholic fatty liver disease
Cave, M. C., Clair, H. B., Hardesty, J. E., Falkner, K. C., Feng, W., Clark, B. J., Sidey, J., Shi, H., Aqel, B. A., McClain, C. J., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.002 · Cited by 279
“Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Wrighton SA, Hancock M, Kim RB, Strom S, Thummel K, Russell CG, Hudson JR Jr, Schuetz EG, Boguski MS.”
BackgroundInfluentialPeroxisome Proliferators Enhance Cyclooxygenase-2 Expression in Epithelial Cells
Meade, E. A., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8328 · Cited by 293
Dreyer, C., Keller, H., Mahfoudi, A., Laudet, V., Krey, G., & Wahli, W. (1993) · Biology of the Cell · doi:10.1016/s0248-4900(05)80176-5 · Cited by 284
Fischer, M., You, M., Matsumoto, M., & Crabb, D. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302140200 · Cited by 291
Metabolic and Additional Vascular Effects of Thiazolidinediones
Martens, F. M. A. C., Visseren, F. L. J., Lemay, J., de Koning, E. J. P., & Rabelink, T. J. (2002) · Drugs · doi:10.2165/00003495-200262100-00004 · Cited by 291
“PPARs are ligand-activated transcription factors belonging to the nuclear receptor superfamily, which include receptors for steroids, retinoid and thyroid hormones.[7-9] Once PPARs are activated by ligand binding, they form heterodimers with the ligand-activated retinoic acid receptor (RXR).”
BackgroundHansen, J. B., Jørgensen, C., Petersen, R. K., Hallenborg, P., De Matteis, R., Bøye, H. A., Petrovic, N., Enerbäck, S., Nedergaard, J., Cinti, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0301964101 · Cited by 287
Metabolic aspects of peroxisomal β-oxidation
Osmundsen, H., Bremer, J., & Pedersen, J. I. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90089-z · Cited by 278
Calnek, D. S., Mazzella, L., Roser, S., Roman, J., & Hart, C. M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000044461.01844.c9 · Cited by 286
Brain regulation of food intake and appetite: molecules and networks
BROBERGER, C. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01553.x · Cited by 251
Regulation of adipocyte differentiation and function by polyunsaturated fatty acids
Madsen, L., Petersen, R. K., & Kristiansen, K. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.03.001 · Cited by 281
“A surprising variety of compounds are able to activate the PPARs [30,65,65–69].”
BackgroundLarsen, T. M., Toubro, S., & Astrup, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802223 · Cited by 282
Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes
Wang, H., & LeCluyse, E. L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00003 · Cited by 278
The peroxisome: an update on mysteries
Islinger, M., Grille, S., Fahimi, H. D., & Schrader, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0941-4 · Cited by 281
“However, the molecular mechanisms behind this phenomenon were only unraveled after the identification of the peroxisome proliferator-activated receptor a (PPARa)—a member of the nuclear receptor superfamily—as the key regulative factor (Issemann and Green 1990).”
BackgroundInoue, I., Goto, S.-I., Matsunaga, T., Nakajima, T., Awata, T., Hokari, S., Komoda, T., & Katayama, S. (2001) · Metabolism · doi:10.1053/meta.2001.19415 · Cited by 283
PPARs and nonalcoholic fatty liver disease
Liss, K. H. H., & Finck, B. N. (2017) · Biochimie · doi:10.1016/j.biochi.2016.11.009 · Cited by 275
“ability of ligands to induce hepatic peroxisome proliferation and resulting hepatocellular carcinoma [30], this phenomenon is specific to rodents [33,34].”
BackgroundNovel Sequence Determinants in Peroxisome Proliferator Signaling
Palmer, C. N. A., Hsu, M.-H., Griffin, K. J., & Johnson, E. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16114 · Cited by 283
Parallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280
“Peroxisome proliferator-activated receptors (PPARs) are members of the steroid/thyroid nuclear receptor superfamily of ligand-activated transcription factors (Issemann and Green, 1990).”
BackgroundYamashita, A., Hayashi, Y., Nemoto-Sasaki, Y., Ito, M., Oka, S., Tanikawa, T., Waku, K., & Sugiura, T. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.10.001 · Cited by 268
Macrophage polarization: the link between inflammation and related diseases
Bashir, S., Sharma, Y., Elahi, A., & Khan, F. (2016) · Inflammation Research · doi:10.1007/s00011-015-0874-1 · Cited by 267
“Following their discovery by Issemann and Green [98] PPAR’s opened the gateway to the study of a number of similar receptors which have types and subtypes generated due to differential RNA splicing and alternate promoter use [99] The nuclear hormone receptor peroxisome proliferator-activated receptor c (PPARc) is a ce…”
BackgroundReactive oxygen species and peroxisomes: Struggling for balance
Bonekamp, N. A., Völkl, A., Fahimi, H. D., & Schrader, M. (2009) · BioFactors · doi:10.1002/biof.48 · Cited by 274
“Peroxisomes respond to various external stimuli, such as the so-called peroxisome proliferators (for example, fatty acids and fibrates), by proliferation via the activation of PPARa [32,47,48].”
Kelly, L. J., Vicario, P. P., Thompson, G. M., Candelore, M. R., Doebber, T. W., Ventre, J., Wu, M. S., Meurer, R., Forrest, M. J., Conner, M. W., et al. (1998) · Endocrinology · doi:10.1210/endo.139.12.6384 · Cited by 268
Towards Fish Lipid Nutrigenomics: Current State and Prospects for Fin-Fish Aquaculture
Leaver, M. J., Bautista, J. M., Björnsson, B. T., Jönsson, E., Krey, G., Tocher, D. R., & Torstensen, B. E. (2008) · Reviews in Fisheries Science · doi:10.1080/10641260802325278 · Cited by 265
“…factors, which were activated by a variety of chemical and pharmacological compounds known to induce peroxisome proliferation in rodents (Issemann and Green, 1990), PPARs have been intensively studied in humans and rodents and have been the subject of several detailed reviews e.g.,…”
BackgroundAnti‐tumor mechanisms of valproate: A novel role for an old drug
Blaheta, R. A., & Cinatl, J. (2002) · Medicinal Research Reviews · doi:10.1002/med.10017 · Cited by 269
Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
Tahri-Joutey, M., Andreoletti, P., Surapureddi, S., Nasser, B., Cherkaoui-Malki, M., & Latruffe, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168969 · Cited by 253
“The identification of PPAR in the 1990s heralded a new era of biotic and xenobiotic sensing by the liver [4].”
BackgroundInfluentialNebert, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-9-1203 · Cited by 276
Regulation of lipogenic enzyme gene expression by nutrients and hormones
Girard, J., Perdereau, D., Foufelle, F., Prip‐Buus, C., & Ferré, P. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.1.7905448 · Cited by 265
“This region could contain a polyunsaturated fatty acid response element that shares some similarity with the peroxisome proliferator-activated receptor (PPAR) described recently (53).”
Free radical biology for medicine: learning from nonalcoholic fatty liver disease
Serviddio, G., Bellanti, F., & Vendemiale, G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.174 · Cited by 267
“PPAR α induces genes involved in mitochondrial as well as peroxisomal and microsomal FA oxidation [90 – 92].”
Qiu, Y.-Y., Zhang, J., Zeng, F.-Y., & Zhu, Y. Z. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106786 · Cited by 271
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Corona, J. C., & Duchen, M. R. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.023 · Cited by 259
“PPARα was cloned as the molecular target of fibrates, cholesterol-lowering compounds that increase hepatic fatty acid oxidation [77].”
BackgroundHepatic peroxisome proliferation in rodents and its significance for humans
Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., & Wiegand, H.-J. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90225-n · Cited by 271
van Raalte, D. H., Li, M., Pritchard, P. H., & Wasan, K. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041444.06122.8d · Cited by 269
“(11) discovered that peroxisome proliferators, a heterogeneous group of compounds, activated one of these orphan nuclear receptors that includes the hypolipidemic drug clofibrate.”
BackgroundFan, C.-Y., Pan, J., Chu, R., Lee, D., Kluckman, K. D., Usuda, N., Singh, I., Yeldandi, A. V., Rao, M. S., Maeda, N., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24698 · Cited by 268
Molecular mechanisms of PFOA-induced toxicity in animals and humans: Implications for health risks
Li, K., Gao, P., Xiang, P., Zhang, X., Cui, X., & Ma, L. Q. (2017) · Environment International · doi:10.1016/j.envint.2016.11.014 · Cited by 260
“PPARα is initially labeled as a hepatic lipid metabolism governor by Issemann and Green (1990).”
Expression of PEX11β Mediates Peroxisome Proliferation in the Absence of Extracellular Stimuli
Schrader, M., Reuber, B. E., Morrell, J. C., Jimenez-Sanchez, G., Obie, C., Stroh, T. A., Valle, D., Schroer, T. A., & Gould, S. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29607 · Cited by 266
PPARs and ERRs: molecular mediators of mitochondrial metabolism
Fan, W., & Evans, R. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.11.002 · Cited by 250
“PPARα was first cloned as the molecular target of fibrates, a class of cholesterol-lowering compounds that increase hepatic FAO [22].”
Campbell, F. M., Kozak, R., Wagner, A., Altarejos, J. Y., Dyck, J. R. B., Belke, D. D., Severson, D. L., Kelly, D. P., & Lopaschuk, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106054200 · Cited by 260
PPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
Gonzalez, F. J., & Shah, Y. M. (2008) · Toxicology · doi:10.1016/j.tox.2007.09.030 · Cited by 262
Mukherjee, R., Jow, L., Noonan, D., & McDonnell, D. P. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90089-2 · Cited by 270
Ren, B., Thelen, A. P., Peters, J. M., Gonzalez, F. J., & Jump, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26827 · Cited by 264
Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation
Castrillo, A., & Tontonoz, P. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.134432 · Cited by 260
Regulation of Bile Acid and Cholesterol Metabolism by PPARs
Li, T., & Chiang, J. Y. L. (2009) · PPAR Research · doi:10.1155/2009/501739 · Cited by 241
“Studies in the past have revealed that the hypolipidemic effects of fibrates are mainly a result of activation of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα), which belongs to the nuclear hormone receptor superfamily [2].”
Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.
Miller, C. W., & Ntambi, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9443 · Cited by 255
Stress induces peroxisome biogenesis genes
Lopez-Huertas, E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6770 · Cited by 254
Transcriptional Activation Of Energy Metabolic Switches In The Developing And Hypertrophied Heart
Lehman, J. J., & Kelly, D. P. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03655.x · Cited by 257
The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Peraza, M. A., Burdick, A. D., Marin, H. E., Gonzalez, F. J., & Peters, J. M. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj062 · Cited by 254
“Peroxisome proliferator-activated receptor-a (PPARa) was the first of three PPARs to be identified, approximately fifteen years ago (Issemann and Green, 1990).”
BackgroundCoordination of inflammation and metabolism by PPAR and LXR nuclear receptors
Hong, C., & Tontonoz, P. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.016 · Cited by 253
“The founding member of the peroxisome proliferator-activated receptor (PPAR) subfamily is PPARα, first identified as the target of fibrates and other compounds that induce peroxisome proliferation in rodents [4].”
BackgroundLodhi, I. J., Yin, L., Jensen-Urstad, A. P. L., Funai, K., Coleman, T., Baird, J. H., El Ramahi, M. K., Razani, B., Song, H., Fu-Hsu, F., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.013 · Cited by 246
“This nuclear receptor family was identified and named based on activation by chemicals that promote proliferation of peroxisomes (Dreyer et al., 1992; Issemann and Green, 1990).”
BackgroundPPARγ signaling and emerging opportunities for improved therapeutics
Wang, S., Dougherty, E. J., & Danner, R. L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.028 · Cited by 248
“Named for its activation by fibrates and other peroxisome proliferators (15), peroxisome proliferator-activated receptor α (PPARα/NR1C1) was first identified in 1990.”
BackgroundPolyunsaturated Fatty Acid Regulation of Gene Expression
Sampath, H., & Ntambi, J. M. (2004) · Nutrition Reviews · doi:10.1111/j.1753-4887.2004.tb00058.x · Cited by 239
Berthou, L., Duverger, N., Emmanuel, F., Langouët, S., Auwerx, J., Guillouzo, A., Fruchart, J. C., Rubin, E., Denèfle, P., Staels, B., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118687 · Cited by 248
Huang, B., Wu, P., Bowker-Kinley, M. M., & Harris, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.2.276 · Cited by 246
“Given that WY-14,643 is a peroxisome proliferator activated receptor- (PPAR- ) activator (14,15), we have proposed that activation of this nuclear hormone receptor promotes PDK4 expression (10).”
BackgroundRegulation of Lipid and Lipoprotein Metabolism by PPAR Activators
Gervois, P., Torra, I. P., Fruchart, J.-C., & Staels, B. (2000) · cclm · doi:10.1515/cclm.2000.002 · Cited by 249
Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand?
Peters, J. M., Cheung, C., & Gonzalez, F. J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0678-9 · Cited by 248
“It was not until 1990 that a receptor was cloned and shown to be activated by this class of chemicals [5] and thus termed the peroxisome proliferator-activated receptor (PPAR).”
BackgroundHu, W. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.2.429 · Cited by 247
“Previous studies have shown that the peroxisome proliferator activated receptor (PPAR) mediates many of the effects of peroxisome proliferators, including perfluorinated compounds (Issemann and Green, 1990).”
BackgroundOrigins of genes: "big bang" or continuous creation?
Keese, P. K., & Gibbs, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9489 · Cited by 246
Corton, J. C., Cunningham, M. L., Hummer, B. T., Lau, C., Meek, B., Peters, J. M., Popp, J. A., Rhomberg, L., Seed, J., & Klaunig, J. E. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.835784 · Cited by 238
The Regulation of Chondrocyte Function by Proinflammatory Mediators: Prostaglandins and Nitric Oxide
Goldring, M. B., & Berenbaum, F. (2004) · Clinical Orthopaedics & Related Research · doi:10.1097/01.blo.0000144484.69656.e4 · Cited by 245
“(PPAR ), which is a transcription factor belonging to the nuclear receptor superfamily.(64) In addition to driving PPAR -dependent adipogenesis,(40) 15d-PGJ2 has been implicated in promoting apoptosis and in promoting and opposing inflammation.”
BackgroundQiao, J. T., Cui, C., Qing, L., Wang, L. S., He, T. Y., Yan, F., Liu, F. Q., Shen, Y. H., Hou, X. G., & Chen, L. (2018) · Metabolism · doi:10.1016/j.metabol.2017.09.010 · Cited by 238
LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues
Dalen, K. T., Dahl, T., Holter, E., Arntsen, B., Londos, C., Sztalryd, C., & Nebb, H. I. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.11.011 · Cited by 235
PPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation
Contreras, A. V., Torres, N., & Tovar, A. R. (2013) · Advances in Nutrition · doi:10.3945/an.113.003798 · Cited by 236
“PPAR-a can be also activated by synthetic ligands such as hypolipidemic drugs that include bezafibrate, fenofibrate, clofibrate, and Wy14643 that induce up- and downregulation of expression of several genes involved in b-oxidation and lipid metabolism (10,37).”
BackgroundVu-Dac, N., Schoonjans, K., Laine, B., Fruchart, J. C., Auwerx, J., & Staels, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47383-8 · Cited by 243
Review of the roles of conjugated linoleic acid in health and disease
Yang, B., Chen, H., Stanton, C., Ross, R. P., Zhang, H., Chen, Y. Q., & Chen, W. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.050 · Cited by 236
The save our sisters project. A social network strategy for reaching rural black women
Eng, E. (1993) · Cancer · doi:10.1002/1097-0142(19930801)72:3+<1071::aid-cncr2820721322>3.0.co;2-v · Cited by 125
Hashimoto, T., Fujita, T., Usuda, N., Cook, W., Qi, C., Peters, J. M., Gonzalez, F. J., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19228 · Cited by 241
Coactivators in PPAR-Regulated Gene Expression
Viswakarma, N., Jia, Y., Bai, L., Vluggens, A., Borensztajn, J., Xu, J., & Reddy, J. K. (2010) · PPAR Research · doi:10.1155/2010/250126 · Cited by 229
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Cai, W., Yang, T., Liu, H., Han, L., Zhang, K., Hu, X., Zhang, X., Yin, K.-J., Gao, Y., Bennett, M. V. L., et al. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.002 · Cited by 236
Tachibana, K., Yamasaki, D., Ishimoto, K., & Doi, T. (2008) · PPAR Research · doi:10.1155/2008/102737 · Cited by 223
“Although peroxisome proliferators have carcinogenic consequences in the liver of rodents, epidemiological studies suggest that similar effects are unlikely to occur in humans [10, 33–36].”
BackgroundInfluentialFatty Acid–Regulated Transcription Factors in the Liver
Jump, D. B., Tripathy, S., & Depner, C. M. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161139 · Cited by 228
“In addition, peroxisome proliferator activated receptors (PPARs) were discovered and found to be regulated by fatty acids (34, 47).”
Background
Metadata
- Authors
- Issemann, I., & Green, S.
- Venue
- Nature
- Published
- 1990-10
- Volume
- 347
- Issue
- 6294
- Pages
- 645-650
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066092624
- Cited by
- 3,519
- References
- 56
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 47 · 2022: 58 · 2021: 71 · 2020: 63 · 2019: 82 · 2018: 74 · 2017: 90 · 2016: 87 · 2015: 94 · 2014: 98 · 2013: 106 · 2012: 133
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- peroxisome proliferator-activated receptors, steroid hormone receptors, ligand-activated transcription factors, peroxisome proliferation, hepatocarcinogens, hypolipidemic effect, cancer risk, receptor cloning
- MeSH terms
- Amino Acid Sequence, Animals, Hypolipidemic Agents, Base Sequence, Binding Sites, Cloning, Molecular, DNA, Humans, Liver, Liver Neoplasms, Experimental, Microbodies, Molecular Sequence Data, Nafenopin, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Steroid, Sequence Homology, Nucleic Acid, Tissue Distribution, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.